Top Markets
Coin of the day
GBS Inc. GBS Inc.

GBS Inc.

GBS
Rank in Stocks #33716
Operating across North America and the Asia-Pacific region, GBS Inc.... Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2 Biosensor, intended as a supplementary diagnostic tool to existing RNA virus detection tests, and is constructing a broad biosensor platform covering diagnostic modalities such as biochemistry, immunology, tumor markers, hormones, and nucleic acids. GBS Inc. maintains a research agreement with the Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic solutions. Founded in 2016 and headquartered in New York, New York, the company adopted its current name, GBS Inc., in September 2019, having previously operated as Glucose Biosensor Systems (Greater China) Holdings, Inc. It operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Share Price
$0.4732
Last synced: 2022-10-26
Market Cap
$7.05M
Change (1 day)
-0.03%
Change (1 year)
0.00%
Country
US
Trade GBS Inc. (GBS)

Category

Stock price history for GBS Inc. (GBS)
Highest end of day price: $0.49 on 2022-10-01

Lowest end of day price: $9.14 on 2020-12-01
Stock price history of GBS Inc. from 2020 to 2026
Annual Stock Price Performance
Year Performance
2022 -69.81%
2021 -82.27%
2020 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$111.15 -15.64%
US
$339.00 -11.24%
US
$91.19 -1.97%
IE
$51.77 -49.83%
US
$91.49 16.90%
US